1.
J Pediatr Pharmacol Ther
; 22(4): 304-313, 2017.
Artículo
en Inglés
| MEDLINE
| ID: mdl-28943827
RESUMEN
We report 6 cases of intravenous levofloxacin use to treat multidrug-resistant nosocomial respiratory infections in neonates with a postmenstrual age ranging from 27 to 42 weeks. Because of a lack of neonatal-specific information for levofloxacin, the usual pediatric dosage (10 mg/kg per dose every 12 hours) was used in these patients. Clinical cure occurred in 5 of the 6 patients. Only minimal short-term adverse effects were noted.